Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in Patients With Obsessive‐Compulsive Disorder?
International Journal of Developmental Neuroscience · 2025
DOI: 10.1002/jdn.70070 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Developmental Neuroscience, 2025. Verfasst von Sinan Altunoz und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Mental Health and Diseases, Balikesir Atatürk City Hospital, Balikesir, Turkey. Hauptthemen laut MEDLINE: Obsessive-Compulsive Disorder, MicroRNAs, Transforming Growth Factor beta. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Balikesir University Scientific Research Projects Unit.
Abstract (Originalsprache)
Introduction
This study investigated the regulation of miRNA‐132‐3p on TGF‐β levels and its association with OCD severity. We hypothesized that miRNA‐132‐3p and TGF‐β influence OCD aetiology and severity, with their levels correlating with disease severity.
Methods
The study included 48 OCD patients diagnosed via SCID‐5‐CV per DSM‐V and 48 matched healthy controls. Blood samples were analysed for miRNA‐132‐3p and TGF‐β using RT‐PCR and ELISA. Participants completed Y‐BOCS, symptom list, HAMA, HAMD, consent and sociodemographic forms.
Results
OCD patients had significantly lower TGF‐β levels ( p = 0.008), negatively correlating with Y‐BOCS scores (r s = −0.220, p = 0.045) and disease duration (r s = −0.473, p = 0.002). miRNA‐132‐3p levels were 1.92 times higher in OCD patients ( p = 0.003), positively correlating with Y‐BOCS scores (r s = 0.208, p = 0.045).
Conclusions
Altered TGF‐β and miRNA‐132‐3p levels may contribute to OCD pathophysiology by affecting BDNF regulation, inflammatory responses (Th1/Th2, Th17/Treg balance) and synaptic plasticity‐related genes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Mental Health and Diseases, Balikesir Atatürk City Hospital, Balikesir, Turkey.
- Department of Mental Health and Diseases, Balikesir University Faculty of Medicine, Balikesir, Turkey.
- Department of Medical Biochemistry, Balikesir University Faculty of Medicine, Balikesir, Turkey.
- Department of Medical Genetics, Balikesir University Faculty of Medicine, Balikesir, Turkey.
- Department of Medical Biology, Balikesir University Faculty of Medicine, Balikesir, Turkey.
ORCID-Profile: Sinan Altunoz, Nazan Dolapoglu, Ozgur Baykan, Hilmi Bolat, Ayla Solmaz Avcikurt, Tunay Karlidere
Förderung
- Balikesir University Scientific Research Projects Unit
Zitieren
APA
Altunoz, S., Dolapoglu, N., Baykan, O., Bolat, H., Avcikurt, A. S., & Karlidere, T. (2025). Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in Patients With Obsessive‐Compulsive Disorder?. International Journal of Developmental Neuroscience. https://doi.org/10.1002/jdn.70070
Vancouver
Altunoz S, Dolapoglu N, Baykan O, Bolat H, Avcikurt AS, Karlidere T. Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in Patients With Obsessive‐Compulsive Disorder?. International Journal of Developmental Neuroscience. 2025. doi:10.1002/jdn.70070
BibTeX
@article{Altunoz2025,
author = {Altunoz, Sinan and Dolapoglu, Nazan and Baykan, Ozgur and Bolat, Hilmi and Avcikurt, Ayla Solmaz and Karlidere, Tunay},
title = {Could Transforming Growth Factor Beta and Target MicroRNA Dysregulation Serve as Biomarkers of Symptom Severity in Patients With Obsessive‐Compulsive Disorder?},
journal = {International Journal of Developmental Neuroscience},
year = {2025},
doi = {10.1002/jdn.70070}
}
EUVIMED